Ladenburg thalmann to host virtual discussion june 22nd with jaguar health ceo and leading patient advocates on impact of cancer therapy-related diarrhea on patients & importance of the patient voice in supportive care

Click here to register for this virtual event taking place at 1:00 pm eastern on june 22, 2023 jaguar recently completed patient enrollment in its ongoing pivotal, phase 3 ontarget clinical trial of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy with or without chemotherapy san francisco, ca / accesswire / june 14, 2023 / jaguar health, inc. (nasdaq:jagx) today announced that ladenburg thalmann is hosting a live virtual "duologue series" discussion at 1:00 p.m. edt on june 22, 2023 with lisa conte, jaguar's founder, president and ceo.
JAGX Ratings Summary
JAGX Quant Ranking